Skip to main content
. Author manuscript; available in PMC: 2014 Apr 4.
Published in final edited form as: Metab Brain Dis. 2014 Mar;29(1):37–45. doi: 10.1007/s11011-013-9440-0

Fig. 2.

Fig. 2

DRα1-MOG-35-55 treatment reduces number of activated CD11b+ cells and their CD74 surface expression in the ischemic brain 96 h after MCAO. a Absolute lymphocytes numbers in the non-ischemic left and ischemic right brain from DRα1-MOG-35-55-treated (n =7) versus Vehicle-treated mice (n =9). b Absolute numbers of CD11b+CD45low, CD11b+CD45high and CD4+ cells in the right brain. c CD74 cell surface expression on CD11b+CD45high cells in the right brain. Data are presented as mean ± SEM. *p <0.05, **p < 0.01, ***p <0.001 Student’s t-test